These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 29409840)
1. Flow Microscopy Imaging Is Sensitive to Characteristics of Subvisible Particles in Peginesatide Formulations Associated With Severe Adverse Reactions. Daniels AL; Randolph TW J Pharm Sci; 2018 May; 107(5):1313-1321. PubMed ID: 29409840 [TBL] [Abstract][Full Text] [Related]
2. Microflow Imaging Analyses Reflect Mechanisms of Aggregate Formation: Comparing Protein Particle Data Sets Using the Kullback-Leibler Divergence. Maddux NR; Daniels AL; Randolph TW J Pharm Sci; 2017 May; 106(5):1239-1248. PubMed ID: 28159641 [TBL] [Abstract][Full Text] [Related]
3. Subvisible Particle Content, Formulation, and Dose of an Erythropoietin Peptide Mimetic Product Are Associated With Severe Adverse Postmarketing Events. Kotarek J; Stuart C; De Paoli SH; Simak J; Lin TL; Gao Y; Ovanesov M; Liang Y; Scott D; Brown J; Bai Y; Metcalfe DD; Marszal E; Ragheb JA J Pharm Sci; 2016 Mar; 105(3):1023-7. PubMed ID: 26886324 [TBL] [Abstract][Full Text] [Related]
4. Characterization of Inherent Particles and Mechanism of Thermal Stress Induced Particle Formation in HSV-2 Viral Vaccine Candidate. Li L; Kirkitadze M; Bhandal K; Roque C; Yang E; Carpick B; Rahman N Curr Pharm Biotechnol; 2017 Nov; 18(8):638-647. PubMed ID: 28914197 [TBL] [Abstract][Full Text] [Related]
5. Processing Impact on Monoclonal Antibody Drug Products: Protein Subvisible Particulate Formation Induced by Grinding Stress. Gikanga B; Eisner DR; Ovadia R; Day ES; Stauch OB; Maa YF PDA J Pharm Sci Technol; 2017; 71(3):172-188. PubMed ID: 27789805 [TBL] [Abstract][Full Text] [Related]
6. Deep Convolutional Neural Network Analysis of Flow Imaging Microscopy Data to Classify Subvisible Particles in Protein Formulations. Calderon CP; Daniels AL; Randolph TW J Pharm Sci; 2018 Apr; 107(4):999-1008. PubMed ID: 29269269 [TBL] [Abstract][Full Text] [Related]
7. Testing Precision Limits of Neural Network-Based Quality Control Metrics in High-Throughput Digital Microscopy. Calderon CP; Ripple DC; Srinivasan C; Ma Y; Carrier MJ; Randolph TW; O'Connor TF Pharm Res; 2022 Feb; 39(2):263-279. PubMed ID: 35080706 [TBL] [Abstract][Full Text] [Related]
8. Variable Threshold Method for Determining the Boundaries of Imaged Subvisible Particles. Cavicchi RE; Collett C; Telikepalli S; Hu Z; Carrier M; Ripple DC J Pharm Sci; 2017 Jun; 106(6):1499-1507. PubMed ID: 28209364 [TBL] [Abstract][Full Text] [Related]
10. Closing the Gap: Counting and Sizing of Particles Across Submicron Range by Flow Cytometry in Therapeutic Protein Products. Zhang L; Shi S; Antochshuk V J Pharm Sci; 2017 Nov; 106(11):3215-3221. PubMed ID: 28625725 [TBL] [Abstract][Full Text] [Related]
17. Characterisation of Stress-Induced Aggregate Size Distributions and Morphological Changes of a Bi-Specific Antibody Using Orthogonal Techniques. Hamrang Z; Hussain M; Tingey K; Tracka M; Casas-Finet JR; Uddin S; van der Walle CF; Pluen A J Pharm Sci; 2015 Aug; 104(8):2473-81. PubMed ID: 26053418 [TBL] [Abstract][Full Text] [Related]
18. Effect of solution properties on the counting and sizing of subvisible particle standards as measured by light obscuration and digital imaging methods. Werk T; Volkin DB; Mahler HC Eur J Pharm Sci; 2014 Mar; 53():95-108. PubMed ID: 24370624 [TBL] [Abstract][Full Text] [Related]
19. Development of Flow Imaging Analysis for Subvisible Particle Characterization in Glatiramer Acetate. Levin I; Zigman S; Komlosh A; Kettenring J J Pharm Sci; 2015 Nov; 104(11):3977-3983. PubMed ID: 26099719 [TBL] [Abstract][Full Text] [Related]
20. Collaborative Study for Analysis of Subvisible Particles Using Flow Imaging and Light Obscuration: Experiences in Japanese Biopharmaceutical Consortium. Kiyoshi M; Shibata H; Harazono A; Torisu T; Maruno T; Akimaru M; Asano Y; Hirokawa M; Ikemoto K; Itakura Y; Iwura T; Kikitsu A; Kumagai T; Mori N; Murase H; Nishimura H; Oda A; Ogawa T; Ojima T; Okabe S; Saito S; Saitoh S; Suetomo H; Takegami K; Takeuchi M; Yasukawa H; Uchiyama S; Ishii-Watabe A J Pharm Sci; 2019 Feb; 108(2):832-841. PubMed ID: 30121316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]